References
- Knight J, Tsodikov A, Cibrik D, et al Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol 2009;27:3354–3362.
- Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106–112.
- Broelsch CE, Whitington PF, Emond JC, et al Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 1991;214:428–437.
- Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003;76:1599–1603.
- Kataoka K, Seo S, Sugawara Y, et al Posttransplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leuk Lymphoma 2010;51:1494–1501.
- Khedmat H, Taheri S. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant 2009;14(4):80–85.
- Dotti G, Fiocchi R, Motta T, et al Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation 2002;74:1095–1102.
- Mañez R, Breinig MC, Linden P, et al Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997;176:1462–1467.
- Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD). Clin Nucl Med 2009;34:386–387.
- Bianchi E, Pascual M, Nicod M, Delaloye AB, Duchosal MA. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation 2008;85:707–712.
- Dufour J, Fey M. What is the current treatment of PTLD after liver transplantation? J Hepatol 2006;44:23–26.
- Evens AM, David KA, Helenowski I, et al Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol 2010;28:1038–1046.